Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis

Details for Australian Patent Application No. 2004210184 (hide)

Owner AstraZeneca AB

Inventors Rubin, Stephen

Agent Davies Collison Cave

Pub. Number AU-B-2004210184

PCT Pub. Number WO2004/069260

Priority 0302572.3 05.02.03 GB

Filing date 3 February 2004

Wipo publication date 19 August 2004

Acceptance publication date 4 January 2007

International Classifications

A61K 31/5685 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/069260 Priority application(s): WO2004/069260

4 January 2007 Application Accepted

  Published as AU-B-2004210184

3 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210190-A protective glove

2004210181-Transdermal granisetron